Beacon Harbor Wealth Advisors, Inc. Bristol Myers Squibb CO Transaction History
Beacon Harbor Wealth Advisors, Inc.
- $422 Million
- Q1 2025
A detailed history of Beacon Harbor Wealth Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Beacon Harbor Wealth Advisors, Inc. holds 120,320 shares of BMY stock, worth $5.64 Million. This represents 1.74% of its overall portfolio holdings.
Number of Shares
120,320
Previous 5,741
1995.8%
Holding current value
$5.64 Million
Previous $324,000
2164.81%
% of portfolio
1.74%
Previous 0.08%
Shares
17 transactions
Others Institutions Holding BMY
# of Institutions
2,736Shares Held
1.59BCall Options Held
26MPut Options Held
24.2M-
Vanguard Group Inc Valley Forge, PA191MShares$8.97 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.06 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.44 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.11 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.6B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...